Multiple sclerosis (MS) is an insidious disease. Patients suffer because their immune system is attacking their own nerve fibers, which inhibits the transmission of nerve signals. People with MS experience mild to severe ...
Apr 17, 2024
0
0
Prasinezumab, a monoclonal antibody, is shown to reduce signs of motor deterioration in individuals with Parkinson's disease (PD) who have rapidly progressing disease, as reported in an exploratory analysis of data from a ...
Apr 16, 2024
0
41
In a joint effort with RIKEN BioResource Research Center and Mitsubishi Tanabe Pharma Corporation, a team of researchers led by Dr. Haruhisa Inoue (Professor, Department of Cell Growth and Differentiation, CiRA) improved ...
Apr 16, 2024
0
0
Manisha Jhamb, M.D., launched the Kidney-CHAMP study five years ago because she saw a looming tsunami of chronic kidney disease cases. She was pulled to find a way to assist the primary care physicians (PCPs) upon whom this ...
Apr 15, 2024
0
0
A new mathematical model offers hope for better prediction and treatment of Alzheimer's disease. Most mathematical models of Alzheimer's are theoretical, focusing on short term molecular and cellular-level changes that cannot ...
Apr 11, 2024
0
3
